Notably, as early as 1988, a study reported decreased levels of complement components C3 and C4 during the follicular phase of the menstrual cycle in patients with endometriosis, highlighting a potential link between complement activity and disease pathogenesis (Meek et al., 1988). This evidence concerns the gene C4A and endometriosis.